[PPARδ may serve as a more potent therapeutic target than PPARγ in atherosclerosis or inflammatory therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE